Consumer genetics and research company offering DNA testing services. Founded in 2006 by Anne Wojcicki, headquartered in South San Francisco, California.
23andMe filed for Chapter 11 bankruptcy in March 2025, raising serious concerns about the fate of genetic data from 15 million customers. Multiple state attorneys general urged users to delete their data before a potential sale.
The UK Information Commissioner's Office fined 23andMe £2.31 million for failing to adequately protect UK customers' personal data in the 2023 data breach that exposed genetic and ancestry information.
All seven independent board members of 23andMe resigned in September 2024, citing concerns about CEO Anne Wojcicki's plan to take the company private, leaving her as the sole remaining board member.
A data breach at 23andMe exposed the personal and genetic ancestry data of approximately 6.9 million users through credential stuffing attacks on the DNA Relatives feature. The company initially failed to detect the breach for months.
23andMe entered a $300 million deal with pharmaceutical giant GSK to share genetic data from its customer database for drug development research, raising consent and data monetization concerns.